Intranasal corticosteroids for non‐allergic rhinitis

Review of 34 studies (n=4,452) was unable to find any clarity as to whether intranasal corticosteroids reduce disease severity vs placebo when measured at up to three months. However, intranasal corticosteroids probably have a higher risk of the adverse effect epistaxis.


Cochrane Database of Systematic Reviews